Product Registration in Phase (Process)
Product Registration in Phase (Process)
in
Malaysia Philippines Singapore Back to Latest News
Product Registration for Indonesia
Product Registration for Indonesia
in
In December 2020, MoH Indonesia approved the PuriBlood leukocyte reduction filter for red blood cells. We are proud to bring the best and fastest RC filters to the Indonesian market. Back to Latest News
Product Registration for Thailand
Product Registration for Thailand
in
In November 2020, the PuriBlood Leukocyte Reduction Filter was approved by MoH Thailand for red blood cells. We are proud to have the best and fastest RC filters to the market in Thailand. Back to Latest News
2020-02-11 Dr. Ushikusa joins PuriBlood as the consultant for Japanese market!
2020-02-11 Dr. Ushikusa joins PuriBlood as the consultant for Japanese market!
in
Welcome, Dr. Ushikusa join us as PuriBlood's consultant for the Japanese market! He is the authority of "Regenerative medicine" in Japan, with his effort to promote the leuko-reduced blood transfusion in Japan, we hope to bring the pets a safe transfusion therapy soon. February 2014
2019-08-09 Exclusive Interview of PuriBlood CEO
2019-08-09 Exclusive Interview of PuriBlood CEO
in
Luke Chen, co-founder and CEO of PuriBlood, speaks about the innovative spin-off technology developed at the R&D Center for Membrane Technology at Chung Yuan Christian University. PuriBlood leukocyte reduction filters have the capacity to purify blood samples twice as fast as current market standards. The
2019-05-21 TFDA approval for leukocyte reduction filters for RBCs!
2019-05-21 TFDA approval for leukocyte reduction filters for RBCs!
in
PuriBlood leukocyte reduction filter for red blood cells has been approved by the TFDA in May 2019! We are proud to introduce you the best and fastest RC filters on the world to you! (We are proud to Introduce you with the world's best and
2018-11-26 Receive FDA Premarket notification approval
2018-11-26 Receive FDA Premarket notification approval
in
To market in the U.S, submitting the premarket notification for USFDA approval is a must. By submitting the 120 validation tests, and in vivo circulation verification, PuriBlood cleared FDA510(K) at Nov. 26, 2018. For more information, please mail to info@puriblood.com Back to Latest News
2018-11-24 Certified with ISO 13485: 2016
2018-11-24 Certified with ISO 13485: 2016
in
Notify body: BSI group Back to Latest News
2020-12-01 Taiwan Healthcare
2020-12-01 Taiwan Healthcare
in
Date: 3rd-6th December Venue: Taipei Nangang Exhibition Center Exhibition information: https://expo.taiwan-healthcare.org/enUS/index.php Back to Exhibitions
2019-08-07 Arab Health 2020, SA-M14
2019-08-07 Arab Health 2020, SA-M14
in
Date: 27th-30th January Venue: Dubai World Trade Centre Booth: SA.M14 Exhibition information: https://www.arabhealthonline.com/en/Home.html For any further information or meeting arrangement, please email to: info@puriblood.com Back to Exhibitions